Objective To assess the efficacy and safety of treatment modalities for major organ
involvement of Behçet's syndrome (BS), in order to inform the update of the EULAR …

Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet's syndrome (BS). The aim of the current effort was to update the …

Macular edema (ME) may complicate anterior, intermediate, and posterior uveitis, which
may be because of various infectious, neoplastic or autoimmune etiologies. BRB breakdown …

Uveitis is characterized by intraocular inflammation involving the uveal tract; its etiologies
generally fall into two broad categories: autoimmune/inflammatory or infectious …

This review focuses on the recent research on the epidemiology, outcome measures,
immunopathogenesis, genetics, clinical manifestations and management of Behçet's …

Behçet's uveitis (BU) is a debilitating manifestation of Behçet's disease, often requiring
prompt and aggressive treatment to prevent vision loss. Glucocorticoids (GCS) serve as a …

Ocular involvement in Behçet disease (BD) is characterized by recurrent inflammatory
attacks and spontaneous resolution of acute inflammatory signs. Both frequency and …

Uveitis is an important cause of vision loss worldwide due to its sight-threatening
complications, especially cystoid macular edema, as well as choroidal neovascularization …

The management of uveitis is challenging for most treating ophthalmologists. The treatment
of uveitis often requires the use of high dose of systemic corticosteroid and …

Purpose: To investigate the results of dexamethasone (DEX) implant in the treatment of eyes
with refractory Behçet posterior uveitis. Methods: A total of 17 eyes of 12 patients with active …